Veracyte, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92337F1075
USD
51.29
0.37 (0.73%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
139.07
140.64
131.87
130.16
114.47
118.63
115.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
139.07
140.64
131.87
130.16
114.47
118.63
115.86
Raw Material Cost
38.49
39.28
42.52
42.41
37.07
42.16
39.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
61.56
54.43
53.39
55.60
54.41
50.20
50.84
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
49.64
54.56
50.71
57.61
59.16
46.59
47.25
Other Expenses
-3.45
-3.36
-3.79
-3.98
-3.71
-3.14
-3.36
Total Expenditure (Excl Depreciation)
115.22
114.70
108.76
115.85
113.52
107.58
103.66
Operating Profit (PBDIT) excl Other Income
23.799999999999997
25.9
23.1
14.299999999999999
1
11.100000000000001
12.2
Other Income
2.75
3.44
-4.06
5.52
4.52
-0.73
4.83
Operating Profit (PBDIT)
32.02
34.68
24.32
25.32
10.84
16.57
22.91
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
3.38
11.26
-0.17
-18.58
1.95
-6.88
-0.18
Gross Profit (PBDT)
100.58
101.35
89.36
87.75
77.40
76.48
76.69
Depreciation
5.43
5.30
5.27
5.49
5.36
6.25
5.88
Profit Before Tax
29.97
40.63
18.89
1.25
7.43
3.44
16.85
Tax
1.27
-0.52
-0.25
2.23
0.38
-1.67
1.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.71
41.15
19.14
-0.98
7.05
5.11
15.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.71
41.15
19.14
-0.98
7.05
5.11
15.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28.71
41.15
19.14
-0.98
7.05
5.11
15.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,344.41
1,309.58
1,257.67
1,221.06
1,194.94
1,175.97
1,176.04
Earnings per share (EPS)
0.35
0.51
0.24
-0.01
0.09
0.06
0.19
Diluted Earnings per share
0.35
0.51
0.24
-0.01
0.09
0.06
0.19
Operating Profit Margin (Excl OI)
17.15%
18.44%
17.53%
11.0%
0.83%
9.32%
10.53%
Gross Profit Margin
25.46%
32.66%
18.32%
5.18%
11.17%
8.17%
19.62%
PAT Margin
20.64%
29.26%
14.51%
-0.75%
6.16%
4.31%
13.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 21.48% vs 18.29% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 310.00% vs 468.42% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 365.08% vs 350.00% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Veracyte, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
139.07
174.06
-34.99
-20.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
139.07
174.06
-34.99
-20.10%
Raw Material Cost
38.49
38.93
-0.44
-1.13%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
61.56
0.00
61.56
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
1.84
-1.84
-100.00%
Selling and Distribution Expenses
49.64
144.21
-94.57
-65.58%
Other Expenses
-3.45
5.65
-9.10
-161.06%
Total Expenditure (Excl Depreciation)
115.22
241.47
-126.25
-52.28%
Operating Profit (PBDIT) excl Other Income
23.85
-67.42
91.27
135.38%
Other Income
2.75
0.00
2.75
Operating Profit (PBDIT)
32.02
-63.30
95.32
150.58%
Interest
0.00
1.84
-1.84
-100.00%
Exceptional Items
3.38
0.00
3.38
Gross Profit (PBDT)
100.58
135.13
-34.55
-25.57%
Depreciation
5.43
4.12
1.31
31.80%
Profit Before Tax
29.97
-69.26
99.23
143.27%
Tax
1.27
1.88
-0.61
-32.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
28.71
-71.14
99.85
140.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28.71
-71.14
99.85
140.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.71
-71.14
99.85
140.36%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,344.41
330.72
1,013.69
306.51%
Earnings per share (EPS)
0.35
-0.62
0.97
156.45%
Diluted Earnings per share
0.35
-0.62
0.97
156.45%
Operating Profit Margin (Excl OI)
17.15%
-38.73%
0.00
55.88%
Gross Profit Margin
25.46%
-37.42%
0.00
62.88%
PAT Margin
20.64%
-40.87%
0.00
61.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 13.91 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -1.07% vs 6.60% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.48% vs 18.29% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.87 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -30.17% vs 115.18% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 310.00% vs 468.42% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.93 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.09% vs 9.86% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 365.08% vs 350.00% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.15%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025